Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 301 to 312 of 312 entries
Sorted by: Best Match Show Resources per page
Early COVID-19 infection: The wide spectrum of extrapulmonary symptoms in elderly patients.

Aging medicine (Milton (N.S.W))

Giovanardi P, Manni B, Vaccina A, Cavazzuti L, Salvia C, Latronico M, Fabbo A.
PMID: 33363266
Aging Med (Milton). 2020 Nov 29; doi: 10.1002/agm2.12136. Epub 2020 Nov 29.

No abstract available.

Cite
Giovanardi P, Manni B, Vaccina A, et al. Early COVID-19 infection: The wide spectrum of extrapulmonary symptoms in elderly patients. Aging Med (Milton). 2020;doi: 10.1002/agm2.12136.
Giovanardi, P., Manni, B., Vaccina, A., Cavazzuti, L., Salvia, C., Latronico, M., & Fabbo, A. (2020). Early COVID-19 infection: The wide spectrum of extrapulmonary symptoms in elderly patients. Aging medicine (Milton (N.S.W)), . https://doi.org/10.1002/agm2.12136
Giovanardi, Paolo, et al. "Early COVID-19 infection: The wide spectrum of extrapulmonary symptoms in elderly patients." Aging medicine (Milton (N.S.W)) vol. (2020). doi: https://doi.org/10.1002/agm2.12136
Giovanardi P, Manni B, Vaccina A, Cavazzuti L, Salvia C, Latronico M, Fabbo A. Early COVID-19 infection: The wide spectrum of extrapulmonary symptoms in elderly patients. Aging Med (Milton). 2020 Nov 29; doi: 10.1002/agm2.12136. Epub 2020 Nov 29. PMID: 33363266; PMCID: PMC7753694.
Copy Download .nbib Format: NLM
Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer.

Frontiers in oncology

Ollivier L, Labbé M, Fradin D, Potiron V, Supiot S.
PMID: 34595122
Front Oncol. 2021 Sep 14;11:744679. doi: 10.3389/fonc.2021.744679. eCollection 2021.

Prostate cancer is the most frequently diagnosed cancer in men and a leading cause of cancer-related death. In recent decades, the development of immunotherapies has resulted in great promise to cure metastatic disease. However, prostate cancer has failed to...

Cite
Ollivier L, Labbé M, Fradin D, et al. Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer. Front Oncol. 2021;11:744679doi: 10.3389/fonc.2021.744679.
Ollivier, L., Labbé, M., Fradin, D., Potiron, V., & Supiot, S. (2021). Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer. Frontiers in oncology, 11744679. https://doi.org/10.3389/fonc.2021.744679
Ollivier, Luc, et al. "Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer." Frontiers in oncology vol. 11 (2021): 744679. doi: https://doi.org/10.3389/fonc.2021.744679
Ollivier L, Labbé M, Fradin D, Potiron V, Supiot S. Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer. Front Oncol. 2021 Sep 14;11:744679. doi: 10.3389/fonc.2021.744679. eCollection 2021. PMID: 34595122; PMCID: PMC8477651.
Copy Download .nbib Format: NLM
Human cholesteryl ester transfer protein lacks lipopolysaccharide transfer activity, but worsens inflammation and sepsis outcomes in mice.

Journal of lipid research

Dusuel A, Deckert V, Pais de Barros JP, van Dongen K, Choubley H, Charron É, Le Guern N, Labbé J, Mandard S, Grober J, Lagrost L, Gautier T.
PMID: 33500240
J Lipid Res. 2020 Dec 15;62:100011. doi: 10.1194/jlr.RA120000704. Epub 2020 Dec 15.

Bacterial lipopolysaccharides (LPSs or endotoxins) can bind most proteins of the lipid transfer/LPS-binding protein (LT/LBP) family in host organisms. The LPS-bound LT/LBP proteins then trigger either an LPS-induced proinflammatory cascade or LPS binding to lipoproteins that are involved in...

Cite
Dusuel A, Deckert V, Pais de Barros JP, et al. Human cholesteryl ester transfer protein lacks lipopolysaccharide transfer activity, but worsens inflammation and sepsis outcomes in mice. J Lipid Res. 2020;62:100011doi: 10.1194/jlr.RA120000704.
Dusuel, A., Deckert, V., Pais de Barros, J. P., van Dongen, K., Choubley, H., Charron, �. �., Le Guern, N., Labbé, J., Mandard, S., Grober, J., Lagrost, L., & Gautier, T. (2020). Human cholesteryl ester transfer protein lacks lipopolysaccharide transfer activity, but worsens inflammation and sepsis outcomes in mice. Journal of lipid research, 62100011. https://doi.org/10.1194/jlr.RA120000704
Dusuel, Aloïs, et al. "Human cholesteryl ester transfer protein lacks lipopolysaccharide transfer activity, but worsens inflammation and sepsis outcomes in mice." Journal of lipid research vol. 62 (2020): 100011. doi: https://doi.org/10.1194/jlr.RA120000704
Dusuel A, Deckert V, Pais de Barros JP, van Dongen K, Choubley H, Charron É, Le Guern N, Labbé J, Mandard S, Grober J, Lagrost L, Gautier T. Human cholesteryl ester transfer protein lacks lipopolysaccharide transfer activity, but worsens inflammation and sepsis outcomes in mice. J Lipid Res. 2020 Dec 15;62:100011. doi: 10.1194/jlr.RA120000704. Epub 2020 Dec 15. PMID: 33500240; PMCID: PMC7859855.
Copy Download .nbib Format: NLM
The PRONTO study: Clinical performance of ID NOW in individuals with compatible SARS-CoV-2 symptoms in walk-in centres-accelerated turnaround time for contact tracing.

Canada communicable disease report = Releve des maladies transmissibles au Canada

Goupil-Sormany I, Longtin J, Dumar J, Jacob-Wagner M, Bouchard F, Romero L, Harvey J, Bestman-Smith J, Provençal M, Beauchemin S, Richard V, Labbé AC.
PMID: 35018141
Can Commun Dis Rep. 2021 Dec 09;47(12):534-542. doi: 10.14745/ccdr.v47i12a04. eCollection 2021 Dec 09.

BACKGROUND: This PRONTO study investigated the clinical performance of the Abbott ID NOWMETHODS: Prospective study conducted from December 2020 to February 2021 in acute symptomatic participants presenting in three walk-in centres in the province of Québec.RESULTS: Valid paired samples...

Cite
Goupil-Sormany I, Longtin J, Dumar J, et al. The PRONTO study: Clinical performance of ID NOW in individuals with compatible SARS-CoV-2 symptoms in walk-in centres-accelerated turnaround time for contact tracing. Can Commun Dis Rep. 2021;47(12):534-542doi: 10.14745/ccdr.v47i12a04.
Goupil-Sormany, I., Longtin, J., Dumar, J., Jacob-Wagner, M., Bouchard, F., Romero, L., Harvey, J., Bestman-Smith, J., Provençal, M., Beauchemin, S., Richard, V., & Labbé, A. C. (2021). The PRONTO study: Clinical performance of ID NOW in individuals with compatible SARS-CoV-2 symptoms in walk-in centres-accelerated turnaround time for contact tracing. Canada communicable disease report = Releve des maladies transmissibles au Canada, 47(12), 534-542. https://doi.org/10.14745/ccdr.v47i12a04
Goupil-Sormany, Isabelle, et al. "The PRONTO study: Clinical performance of ID NOW in individuals with compatible SARS-CoV-2 symptoms in walk-in centres-accelerated turnaround time for contact tracing." Canada communicable disease report = Releve des maladies transmissibles au Canada vol. 47,12 (2021): 534-542. doi: https://doi.org/10.14745/ccdr.v47i12a04
Goupil-Sormany I, Longtin J, Dumar J, Jacob-Wagner M, Bouchard F, Romero L, Harvey J, Bestman-Smith J, Provençal M, Beauchemin S, Richard V, Labbé AC. The PRONTO study: Clinical performance of ID NOW in individuals with compatible SARS-CoV-2 symptoms in walk-in centres-accelerated turnaround time for contact tracing. Can Commun Dis Rep. 2021 Dec 09;47(12):534-542. doi: 10.14745/ccdr.v47i12a04. eCollection 2021 Dec 09. PMID: 35018141; PMCID: PMC8699396.
Copy Download .nbib Format: NLM
The PRONTO study: Clinical performance of ID NOW in individuals with compatible SARS-CoV-2 symptoms in walk-in centres-accelerated turnaround time for contact tracing.

Canada communicable disease report = Releve des maladies transmissibles au Canada

Goupil-Sormany I, Longtin J, Dumar J, Jacob-Wagner M, Bouchard F, Romero L, Harvey J, Bestman-Smith J, Provençal M, Beauchemin S, Richard V, Labbé AC.
PMID: 35018141
Can Commun Dis Rep. 2021 Dec 09;47(12):534-542. doi: 10.14745/ccdr.v47i12a04. eCollection 2021 Dec 09.

BACKGROUND: This PRONTO study investigated the clinical performance of the Abbott ID NOWMETHODS: Prospective study conducted from December 2020 to February 2021 in acute symptomatic participants presenting in three walk-in centres in the province of Québec.RESULTS: Valid paired samples...

Cite
Goupil-Sormany I, Longtin J, Dumar J, et al. The PRONTO study: Clinical performance of ID NOW in individuals with compatible SARS-CoV-2 symptoms in walk-in centres-accelerated turnaround time for contact tracing. Can Commun Dis Rep. 2021;47(12):534-542doi: 10.14745/ccdr.v47i12a04.
Goupil-Sormany, I., Longtin, J., Dumar, J., Jacob-Wagner, M., Bouchard, F., Romero, L., Harvey, J., Bestman-Smith, J., Provençal, M., Beauchemin, S., Richard, V., & Labbé, A. C. (2021). The PRONTO study: Clinical performance of ID NOW in individuals with compatible SARS-CoV-2 symptoms in walk-in centres-accelerated turnaround time for contact tracing. Canada communicable disease report = Releve des maladies transmissibles au Canada, 47(12), 534-542. https://doi.org/10.14745/ccdr.v47i12a04
Goupil-Sormany, Isabelle, et al. "The PRONTO study: Clinical performance of ID NOW in individuals with compatible SARS-CoV-2 symptoms in walk-in centres-accelerated turnaround time for contact tracing." Canada communicable disease report = Releve des maladies transmissibles au Canada vol. 47,12 (2021): 534-542. doi: https://doi.org/10.14745/ccdr.v47i12a04
Goupil-Sormany I, Longtin J, Dumar J, Jacob-Wagner M, Bouchard F, Romero L, Harvey J, Bestman-Smith J, Provençal M, Beauchemin S, Richard V, Labbé AC. The PRONTO study: Clinical performance of ID NOW in individuals with compatible SARS-CoV-2 symptoms in walk-in centres-accelerated turnaround time for contact tracing. Can Commun Dis Rep. 2021 Dec 09;47(12):534-542. doi: 10.14745/ccdr.v47i12a04. eCollection 2021 Dec 09. PMID: 35018141; PMCID: PMC8699396.
Copy Download .nbib Format: NLM
Challenges of providing HIV pre-exposure prophylaxis in Martinique, French West Indies.

Sexually transmitted infections

Cuzin L, Cabras O, Marquise A, Pierre-François S, Pircher M, Cabié A.
PMID: 34400577
Sex Transm Infect. 2021 Aug 16; doi: 10.1136/sextrans-2021-055158. Epub 2021 Aug 16.

No abstract available.

Cite
Cuzin L, Cabras O, Marquise A, et al. Challenges of providing HIV pre-exposure prophylaxis in Martinique, French West Indies. Sex Transm Infect. 2021;doi: 10.1136/sextrans-2021-055158.
Cuzin, L., Cabras, O., Marquise, A., Pierre-François, S., Pircher, M., Cabié, A. (2021). Challenges of providing HIV pre-exposure prophylaxis in Martinique, French West Indies. Sexually transmitted infections, . https://doi.org/10.1136/sextrans-2021-055158
Cuzin, Lise, et al. "Challenges of providing HIV pre-exposure prophylaxis in Martinique, French West Indies." Sexually transmitted infections vol. (2021). doi: https://doi.org/10.1136/sextrans-2021-055158
Cuzin L, Cabras O, Marquise A, Pierre-François S, Pircher M, Cabié A. Challenges of providing HIV pre-exposure prophylaxis in Martinique, French West Indies. Sex Transm Infect. 2021 Aug 16; doi: 10.1136/sextrans-2021-055158. Epub 2021 Aug 16. PMID: 34400577.
Copy Download .nbib Format: NLM
Figure Correction: Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study.

JMIR medical informatics

Entezarjou A, Calling S, Bhattacharyya T, Nymberg VM, Vigren L, Labaf A, Jakobsson U, Midlöv P.
PMID: 34889754
JMIR Med Inform. 2021 Nov 26;9(11):e34529. doi: 10.2196/34529.

[This corrects the article DOI: 10.2196/25473.].

Cite
Entezarjou A, Calling S, Bhattacharyya T, et al. Figure Correction: Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study. JMIR Med Inform. 2021;9(11):e34529doi: 10.2196/34529.
Entezarjou, A., Calling, S., Bhattacharyya, T., Nymberg, V. M., Vigren, L., Labaf, A., Jakobsson, U., & Midlöv, P. (2021). Figure Correction: Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study. JMIR medical informatics, 9(11), e34529. https://doi.org/10.2196/34529
Entezarjou, Artin, et al. "Figure Correction: Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study." JMIR medical informatics vol. 9,11 (2021): e34529. doi: https://doi.org/10.2196/34529
Entezarjou A, Calling S, Bhattacharyya T, Nymberg VM, Vigren L, Labaf A, Jakobsson U, Midlöv P. Figure Correction: Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study. JMIR Med Inform. 2021 Nov 26;9(11):e34529. doi: 10.2196/34529. PMID: 34889754.
Copy Download .nbib Format: NLM
[Artificial intelligence and glaucoma: A literature review].

Journal francais d'ophtalmologie

Bunod R, Augstburger E, Brasnu E, Labbe A, Baudouin C.
PMID: 34991909
J Fr Ophtalmol. 2022 Jan 03; doi: 10.1016/j.jfo.2021.11.002. Epub 2022 Jan 03.

In recent years, research in artificial intelligence (AI) has experienced an unprecedented surge in the field of ophthalmology, in particular glaucoma. The diagnosis and follow-up of glaucoma is complex and relies on a body of clinical evidence and ancillary...

Cite
Bunod R, Augstburger E, Brasnu E, et al. Intelligence artificielle et glaucome : une revue de la littérature. [Artificial intelligence and glaucoma: A literature review]. J Fr Ophtalmol. 2022;doi: 10.1016/j.jfo.2021.11.002.
Bunod, R., Augstburger, E., Brasnu, E., Labbe, A., & Baudouin, C. (2022). Intelligence artificielle et glaucome : une revue de la littérature. [Artificial intelligence and glaucoma: A literature review]. Journal francais d'ophtalmologie, . https://doi.org/10.1016/j.jfo.2021.11.002
Bunod, R, et al. "Intelligence artificielle et glaucome : une revue de la littérature." [Artificial intelligence and glaucoma: A literature review]. Journal francais d'ophtalmologie vol. (2022). doi: https://doi.org/10.1016/j.jfo.2021.11.002
Bunod R, Augstburger E, Brasnu E, Labbe A, Baudouin C. Intelligence artificielle et glaucome : une revue de la littérature. [Artificial intelligence and glaucoma: A literature review]. J Fr Ophtalmol. 2022 Jan 03; doi: 10.1016/j.jfo.2021.11.002. Epub 2022 Jan 03. French. PMID: 34991909.
Copy Download .nbib Format: NLM
A General .

Chem

Dow NW, Cabré A, MacMillan DWC.
PMID: 34423174
Chem. 2021 Jul 08;7(7):1827-1842. doi: 10.1016/j.chempr.2021.05.005. Epub 2021 Jun 16.

The catalytic union of amides, sulfonamides, anilines, imines or

Cite
Dow NW, Cabré A, MacMillan DWC. A General . Chem. 2021;7(7):1827-1842doi: 10.1016/j.chempr.2021.05.005.
Dow, N. W., Cabré, A., & MacMillan, D. W. C. (2021). A General . Chem, 7(7), 1827-1842. https://doi.org/10.1016/j.chempr.2021.05.005
Dow, Nathan W, et al. "A General ." Chem vol. 7,7 (2021): 1827-1842. doi: https://doi.org/10.1016/j.chempr.2021.05.005
Dow NW, Cabré A, MacMillan DWC. A General . Chem. 2021 Jul 08;7(7):1827-1842. doi: 10.1016/j.chempr.2021.05.005. Epub 2021 Jun 16. PMID: 34423174; PMCID: PMC8372964.
Copy Download .nbib Format: NLM
Infodemic Signal Detection During the COVID-19 Pandemic: Development of a Methodology for Identifying Potential Information Voids in Online Conversations.

JMIR infodemiology

Purnat TD, Vacca P, Czerniak C, Ball S, Burzo S, Zecchin T, Wright A, Bezbaruah S, Tanggol F, Dubé È, Labbé F, Dionne M, Lamichhane J, Mahajan A, Briand S, Nguyen T.
PMID: 34447926
JMIR Infodemiology. 2021 Jul 28;1(1):e30971. doi: 10.2196/30971. eCollection 2021.

BACKGROUND: The COVID-19 pandemic has been accompanied by an OBJECTIVE: In this work, we aimed to develop a practical, structured approach to identify narratives in public online conversations on social media platforms where concerns or confusion exist or where...

Cite
Purnat TD, Vacca P, Czerniak C, et al. Infodemic Signal Detection During the COVID-19 Pandemic: Development of a Methodology for Identifying Potential Information Voids in Online Conversations. JMIR Infodemiology. 2021;1(1):e30971doi: 10.2196/30971.
Purnat, T. D., Vacca, P., Czerniak, C., Ball, S., Burzo, S., Zecchin, T., Wright, A., Bezbaruah, S., Tanggol, F., Dubé, �. �., Labbé, F., Dionne, M., Lamichhane, J., Mahajan, A., Briand, S., & Nguyen, T. (2021). Infodemic Signal Detection During the COVID-19 Pandemic: Development of a Methodology for Identifying Potential Information Voids in Online Conversations. JMIR infodemiology, 1(1), e30971. https://doi.org/10.2196/30971
Purnat, Tina D, et al. "Infodemic Signal Detection During the COVID-19 Pandemic: Development of a Methodology for Identifying Potential Information Voids in Online Conversations." JMIR infodemiology vol. 1,1 (2021): e30971. doi: https://doi.org/10.2196/30971
Purnat TD, Vacca P, Czerniak C, Ball S, Burzo S, Zecchin T, Wright A, Bezbaruah S, Tanggol F, Dubé È, Labbé F, Dionne M, Lamichhane J, Mahajan A, Briand S, Nguyen T. Infodemic Signal Detection During the COVID-19 Pandemic: Development of a Methodology for Identifying Potential Information Voids in Online Conversations. JMIR Infodemiology. 2021 Jul 28;1(1):e30971. doi: 10.2196/30971. eCollection 2021. PMID: 34447926; PMCID: PMC8330887.
Copy Download .nbib Format: NLM
High mean arterial pressure target to improve sepsis-associated acute kidney injury in patients with prior hypertension: a feasibility study.

Annals of intensive care

Dewitte A, Labat A, Duvignaud PA, Bouche G, Joannes-Boyau O, Ripoche J, Hilbert G, Gruson D, Rubin S, Ouattara A, Boyer A, Combe C.
PMID: 34553274
Ann Intensive Care. 2021 Sep 22;11(1):139. doi: 10.1186/s13613-021-00925-2.

BACKGROUND: The optimal mean arterial pressure (MAP) in cases of septic shock is still a matter of debate in patients with prior hypertension. An MAP between 75 and 85 mmHg can improve glomerular filtration rate (GFR) but its effect...

Cite
Dewitte A, Labat A, Duvignaud PA, et al. High mean arterial pressure target to improve sepsis-associated acute kidney injury in patients with prior hypertension: a feasibility study. Ann Intensive Care. 2021;11(1):139doi: 10.1186/s13613-021-00925-2.
Dewitte, A., Labat, A., Duvignaud, P. A., Bouche, G., Joannes-Boyau, O., Ripoche, J., Hilbert, G., Gruson, D., Rubin, S., Ouattara, A., Boyer, A., & Combe, C. (2021). High mean arterial pressure target to improve sepsis-associated acute kidney injury in patients with prior hypertension: a feasibility study. Annals of intensive care, 11(1), 139. https://doi.org/10.1186/s13613-021-00925-2
Dewitte, Antoine, et al. "High mean arterial pressure target to improve sepsis-associated acute kidney injury in patients with prior hypertension: a feasibility study." Annals of intensive care vol. 11,1 (2021): 139. doi: https://doi.org/10.1186/s13613-021-00925-2
Dewitte A, Labat A, Duvignaud PA, Bouche G, Joannes-Boyau O, Ripoche J, Hilbert G, Gruson D, Rubin S, Ouattara A, Boyer A, Combe C. High mean arterial pressure target to improve sepsis-associated acute kidney injury in patients with prior hypertension: a feasibility study. Ann Intensive Care. 2021 Sep 22;11(1):139. doi: 10.1186/s13613-021-00925-2. PMID: 34553274; PMCID: PMC8458519.
Copy Download .nbib Format: NLM
Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study.

JMIR medical informatics

Entezarjou A, Calling S, Bhattacharyya T, Milos Nymberg V, Vigren L, Labaf A, Jakobsson U, Midlöv P.
PMID: 33720032
JMIR Med Inform. 2021 Mar 15;9(3):e25473. doi: 10.2196/25473.

BACKGROUND: Direct-to-consumer telemedicine is an increasingly used modality to access primary care. Previous research on assessment using synchronous virtual visits showed mixed results regarding antibiotic prescription rates, and research on assessment using asynchronous chat-based eVisits is lacking.OBJECTIVE: The goal...

Cite
Entezarjou A, Calling S, Bhattacharyya T, et al. Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study. JMIR Med Inform. 2021;9(3):e25473doi: 10.2196/25473.
Entezarjou, A., Calling, S., Bhattacharyya, T., Milos Nymberg, V., Vigren, L., Labaf, A., Jakobsson, U., & Midlöv, P. (2021). Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study. JMIR medical informatics, 9(3), e25473. https://doi.org/10.2196/25473
Entezarjou, Artin, et al. "Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study." JMIR medical informatics vol. 9,3 (2021): e25473. doi: https://doi.org/10.2196/25473
Entezarjou A, Calling S, Bhattacharyya T, Milos Nymberg V, Vigren L, Labaf A, Jakobsson U, Midlöv P. Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study. JMIR Med Inform. 2021 Mar 15;9(3):e25473. doi: 10.2196/25473. PMID: 33720032; PMCID: PMC8077790.
Copy Download .nbib Format: NLM
Showing 301 to 312 of 312 entries